Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4-5 patients.
- DOI
- 10.1371/journal.pone.0353258
- Published
- 2026
- Container
- PloS one
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1371/journal.pone.0353258,
title = {Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4-5 patients.},
author = {Liuhto N and Tuominen J and Manni N and Hakamäki M and Lankinen R and Toukola T and Virtanen J and Metsärinne K and Järvisalo MJ and Hellman T},
year = {2026},
journal = {PloS one},
doi = {10.1371/journal.pone.0353258},
url = {https://doi.org/10.1371/journal.pone.0353258}
}RIS
TY - JOUR TI - Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4-5 patients. AU - Liuhto N AU - Tuominen J AU - Manni N AU - Hakamäki M AU - Lankinen R AU - Toukola T AU - Virtanen J AU - Metsärinne K AU - Järvisalo MJ AU - Hellman T PY - 2026 JO - PloS one DO - 10.1371/journal.pone.0353258 UR - https://doi.org/10.1371/journal.pone.0353258 ER -
APA
N, L., J, T., N, M., M, H., R, L., T, T., J, V., K, M., MJ, J., & T, H. (2026). Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4-5 patients.. PloS one. https://doi.org/10.1371/journal.pone.0353258
Source records
- pubmed · retrieved 2026-09-25T16:42:19.767Z